Gene Therapy For Parkinson’s Disease Market Report 2026
Download Free Sample Buy Now
Gene Therapy For Parkinson’s Disease Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Gene Therapy For Parkinson’s Disease Market Report 2026

Global Outlook – By Therapy Type (In Vivo Gene Therapy, Ex Vivo Gene Therapy), By Vector Type (Viral Vectors, Non-Viral Vectors), By Target Gene (Aromatic L-Amino Acid Decarboxylase (AADC), Glial Cell Line-Derived Neurotrophic Factor (GDNF), Neurturin, Other Target Genes), By Delivery Method (Intracerebral, Intravenous, Other Delivery Methods), By End-User (Hospitals, Specialty Clinics, Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gene Therapy For Parkinson’s Disease Market Overview

• Gene Therapy For Parkinson’s Disease market size has reached to $0.64 billion in 2025

• Expected to grow to $2.05 billion in 2030 at a compound annual growth rate (CAGR) of 26%

• Growth Driver: Growing Interest In Personalized Medicine Driving The Growth Of The Market Due To Rising Demand For Targeted And Effective Treatments

• Market Trend: Accelerating Development Of Innovative Gene Therapies

• North America was the largest region in 2025.

What Is Covered Under Gene Therapy For Parkinson’s Disease Market?

Gene therapy for Parkinson’s disease refers to the use of genetic techniques to introduce, repair, or regulate genes within brain cells. It is designed to restore dopamine production, protect nerve cells, or correct disease-related mutations. The approach aims to slow disease progression and provide sustained symptom relief.

The main therapy types of gene therapy for parkinson’s disease are in vivo gene therapy and ex vivo gene therapy. In vivo gene therapy refers to the direct delivery of genetic material into the patient’s body, typically using viral or non-viral vectors, to restore or enhance the function of specific genes involved in Parkinson’s disease progression. These therapies target genes such as aromatic L-amino acid decarboxylase (AADC), glial cell line-derived neurotrophic factor (GDNF), neurturin, and other related genes, and are administered through delivery methods including intracerebral, intravenous, and other approaches. The key end-users include hospitals, specialty clinics, research institutes, and others.

Gene Therapy For Parkinson’s Disease Market Global Report 2026 Market Report bar graph

What Is The Gene Therapy For Parkinson’s Disease Market Size and Share 2026?

The gene therapy for parkinson’s disease market size has grown exponentially in recent years. It will grow from $0.64 billion in 2025 to $0.81 billion in 2026 at a compound annual growth rate (CAGR) of 26.3%. The growth in the historic period can be attributed to advances in viral vector engineering, increased understanding of parkinson’s disease pathology, expansion of neuroscience research funding, availability of improved delivery technologies, early clinical trial successes.

What Is The Gene Therapy For Parkinson’s Disease Market Growth Forecast?

The gene therapy for parkinson’s disease market size is expected to see exponential growth in the next few years. It will grow to $2.05 billion in 2030 at a compound annual growth rate (CAGR) of 26.0%. The growth in the forecast period can be attributed to increasing investments in neurodegenerative disease therapies, rising adoption of personalized gene therapy approaches, expansion of late-stage clinical pipelines, growing demand for disease-modifying treatments, advancement of minimally invasive delivery techniques. Major trends in the forecast period include increasing development of viral vector-based therapies, rising focus on dopamine restoration approaches, growing use of neurotrophic factor gene delivery, expansion of precision intracerebral delivery methods, enhanced emphasis on long-term therapeutic efficacy.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Gene Therapy For Parkinson’s Disease Market Segmentation

1) By Therapy Type: In Vivo Gene Therapy, Ex Vivo Gene Therapy

2) By Vector Type: Viral Vectors, Non-Viral Vectors

3) By Target Gene: Aromatic L-Amino Acid Decarboxylase (AADC), Glial Cell Line-Derived Neurotrophic Factor (GDNF), Neurturin, Other Target Genes

4) By Delivery Method: Intracerebral, Intravenous, Other Delivery Methods

5) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By In Vivo Gene Therapy: Viral Vectors, Non-Viral Vectors

2) By Ex Vivo Gene Therapy: Autologous Cell-Based Gene Therapy, Allogeneic Cell-Based Gene Therapy

What Is The Driver Of The Gene Therapy For Parkinson’s Disease Market?

The growing interest in personalized medicine is expected to propel the growth of the gene therapy for Parkinson’s disease market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to an individual's genetic makeup, lifestyle, and environment. Interest in personalized medicine is rising due to the growing demand for targeted therapies that improve treatment effectiveness while minimizing adverse side effects. Gene therapy for Parkinson’s disease in personalized medicine is used to deliver tailored genetic modifications that restore dopamine function and address individual patient-specific disease mechanisms. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the US Food and Drug Administration (FDA) granted approval for 16 new personalized treatments for rare disease patients, marking a substantial increase from the 6 approvals in 2022. Therefore, the growing interest in personalized medicine is driving the growth of gene therapy for Parkinson’s disease industry.

Key Players In The Global Gene Therapy For Parkinson’s Disease Market

Major companies operating in the gene therapy for parkinson’s disease market are Merck & Co. Inc., Bayer AG, Sanofi S.A., Eli Lilly and Company, Biogen Inc., PTC Therapeutics Inc., Zambon S.p.A., Oxford BioMedica plc, Voyager Therapeutics Inc., Insilico Medicine Inc., Spur Therapeutics Inc., Cerevance Inc., MeiraGTx Holdings plc, BlackfinBio Inc., Partner Therapeutics Inc., Kenai Therapeutics Inc., CureSen Therapeutics Inc., BioVie Inc., Clexio Biosciences Ltd., Tetraneuron S.L.

Global Gene Therapy For Parkinson’s Disease Market Trends and Insights

Major companies are operating in the gene therapy for Parkinson’s disease market, focusing on developing more precise therapy, such as regenerative medicine advanced therapy, to enhance neuronal survival, restore dopamine function, and provide long-lasting disease-modifying benefits for patients with Parkinson’s disease. Regenerative medicine advanced therapy (RMAT) refers to a special United States Food and Drug Administration (FDA) designation granted to regenerative medicine products, such as cell therapies, gene therapies, and tissue-engineered products, that are intended to treat, modify, reverse, or cure serious or life-threatening diseases. For instance, in February 2025, Asklepios BioPharmaceutical, Inc. (AskBio), a US-based gene therapy company, introduced AB-1005, an investigational AAV2-GDNF gene therapy that received FDA regenerative medicine advanced therapy (RMAT) designation. The designation, which is intended to expedite the development and review of promising therapies, was granted based on data submitted by AskBio, including clinical evidence from its Phase Ib open-label, uncontrolled trial, demonstrating AB-1005’s potential to slow disease progression and improve motor function in Parkinson’s patients.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Gene Therapy For Parkinson’s Disease Market?

In January 2025, BlackfinBio Limited, a UK-based provider of clinical-stage gene therapy solutions for rare neurological and dopamine-deficiency disorders, acquired the Parkinson’s patent portfolio from Oxford Biomedica plc for an undisclosed amount. Through this acquisition, BlackfinBio aims to advance its BFB-201 program targeting Parkinson’s disease and leverage Oxford Biomedica’s expertise in gene and cell therapy IP to accelerate therapeutic development. Oxford Biomedica plc is a UK-based provider of gene and cell therapy development and vector technologies, bringing valuable intellectual property that complements.

Regional Insights

North America was the largest region in the gene therapy for parkinson’s disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy for parkinson’s disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gene therapy for parkinson’s disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gene Therapy For Parkinson’s Disease Market?

The gene therapy for parkinson’s disease market consists of revenues earned by entities by providing services such as genetic counseling, preclinical studies, clinical trial management, and personalized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene therapy for parkinson’s disease market also includes sales of viral vectors, aromatic L-amino acid decarboxylase (AADC) gene therapy, glutamic acid decarboxylase (GAD) gene therapy, glial cell line-derived neurotrophic factor (GDNF) or neurturin-based neurotrophic therapies, and glucocerebrosidase (GBA)-targeted gene therapies. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gene Therapy For Parkinson’s Disease Market Report 2026?

The gene therapy for parkinson’s disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gene therapy for parkinson’s disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gene Therapy For Parkinson’s Disease Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gene Therapy For Parkinson’s Disease Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gene Therapy For Parkinson’s Disease Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gene Therapy For Parkinson’s Disease Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Immersive Technologies (Ar/Vr/Xr)

4.2. Major Trends

4.2.1 Increasing Development Of Viral Vector-Based Therapies

4.2.2 Rising Focus On Dopamine Restoration Approaches

4.2.3 Growing Use Of Neurotrophic Factor Gene Delivery

4.2.4 Expansion Of Precision Intracerebral Delivery Methods

4.2.5 Enhanced Emphasis On Long-Term Therapeutic Efficacy

5. Gene Therapy For Parkinson’s Disease Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Neurology Clinics

5.3 Research Institutes

5.4 Gene Therapy Developers

5.5 Academic Medical Centers

6. Gene Therapy For Parkinson’s Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gene Therapy For Parkinson’s Disease Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gene Therapy For Parkinson’s Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gene Therapy For Parkinson’s Disease Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gene Therapy For Parkinson’s Disease Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gene Therapy For Parkinson’s Disease Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gene Therapy For Parkinson’s Disease Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gene Therapy For Parkinson’s Disease Market Segmentation

9.1. Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

In Vivo Gene Therapy, Ex Vivo Gene Therapy

9.2. Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Vectors, Non-Viral Vectors

9.3. Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Aromatic L-Amino Acid Decarboxylase (AADC), Glial Cell Line-Derived Neurotrophic Factor (GDNF), Neurturin, Other Target Genes

9.4. Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intracerebral, Intravenous, Other Delivery Methods

9.5. Global Gene Therapy For Parkinson’s Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Research Institutes, Other End-Users

9.6. Global Gene Therapy For Parkinson’s Disease Market, Sub-Segmentation Of In Vivo Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Vectors, Non-Viral Vectors

9.7. Global Gene Therapy For Parkinson’s Disease Market, Sub-Segmentation Of Ex Vivo Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Autologous Cell-Based Gene Therapy, Allogeneic Cell-Based Gene Therapy

10. Gene Therapy For Parkinson’s Disease Market Regional And Country Analysis

10.1. Global Gene Therapy For Parkinson’s Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gene Therapy For Parkinson’s Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gene Therapy For Parkinson’s Disease Market

11.1. Asia-Pacific Gene Therapy For Parkinson’s Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gene Therapy For Parkinson’s Disease Market

12.1. China Gene Therapy For Parkinson’s Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gene Therapy For Parkinson’s Disease Market

13.1. India Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gene Therapy For Parkinson’s Disease Market

14.1. Japan Gene Therapy For Parkinson’s Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gene Therapy For Parkinson’s Disease Market

15.1. Australia Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gene Therapy For Parkinson’s Disease Market

16.1. Indonesia Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gene Therapy For Parkinson’s Disease Market

17.1. South Korea Gene Therapy For Parkinson’s Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gene Therapy For Parkinson’s Disease Market

18.1. Taiwan Gene Therapy For Parkinson’s Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gene Therapy For Parkinson’s Disease Market

19.1. South East Asia Gene Therapy For Parkinson’s Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gene Therapy For Parkinson’s Disease Market

20.1. Western Europe Gene Therapy For Parkinson’s Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gene Therapy For Parkinson’s Disease Market

21.1. UK Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gene Therapy For Parkinson’s Disease Market

22.1. Germany Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gene Therapy For Parkinson’s Disease Market

23.1. France Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gene Therapy For Parkinson’s Disease Market

24.1. Italy Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gene Therapy For Parkinson’s Disease Market

25.1. Spain Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gene Therapy For Parkinson’s Disease Market

26.1. Eastern Europe Gene Therapy For Parkinson’s Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gene Therapy For Parkinson’s Disease Market

27.1. Russia Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gene Therapy For Parkinson’s Disease Market

28.1. North America Gene Therapy For Parkinson’s Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gene Therapy For Parkinson’s Disease Market

29.1. USA Gene Therapy For Parkinson’s Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gene Therapy For Parkinson’s Disease Market

30.1. Canada Gene Therapy For Parkinson’s Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gene Therapy For Parkinson’s Disease Market

31.1. South America Gene Therapy For Parkinson’s Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gene Therapy For Parkinson’s Disease Market

32.1. Brazil Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gene Therapy For Parkinson’s Disease Market

33.1. Middle East Gene Therapy For Parkinson’s Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gene Therapy For Parkinson’s Disease Market

34.1. Africa Gene Therapy For Parkinson’s Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Segmentation By Vector Type, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gene Therapy For Parkinson’s Disease Market Regulatory and Investment Landscape

36. Gene Therapy For Parkinson’s Disease Market Competitive Landscape And Company Profiles

36.1. Gene Therapy For Parkinson’s Disease Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gene Therapy For Parkinson’s Disease Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gene Therapy For Parkinson’s Disease Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Gene Therapy For Parkinson’s Disease Market Other Major And Innovative Companies

PTC Therapeutics Inc., Zambon S.p.A., Oxford BioMedica plc, Voyager Therapeutics Inc., Insilico Medicine Inc., Spur Therapeutics Inc., Cerevance Inc., MeiraGTx Holdings plc, BlackfinBio Inc., Partner Therapeutics Inc., Kenai Therapeutics Inc., CureSen Therapeutics Inc., BioVie Inc., Clexio Biosciences Ltd., Tetraneuron S.L.

38. Global Gene Therapy For Parkinson’s Disease Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gene Therapy For Parkinson’s Disease Market

40. Gene Therapy For Parkinson’s Disease Market High Potential Countries, Segments and Strategies

40.1 Gene Therapy For Parkinson’s Disease Market In 2030 - Countries Offering Most New Opportunities

40.2 Gene Therapy For Parkinson’s Disease Market In 2030 - Segments Offering Most New Opportunities

40.3 Gene Therapy For Parkinson’s Disease Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Gene Therapy For Parkinson’s Disease Market, Overview Of Key Products - Product Examples
  • Table 2: Global Gene Therapy For Parkinson’s Disease Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Gene Therapy For Parkinson’s Disease Market, Supply Chain Analysis
  • Table 4: Global Gene Therapy For Parkinson’s Disease Market, Major Raw Material Providers
  • Table 5: Global Gene Therapy For Parkinson’s Disease Market, Major Resource Providers
  • Table 6: Global Gene Therapy For Parkinson’s Disease Market, Major Manufacturers (Suppliers)
  • Table 7: Global Gene Therapy For Parkinson’s Disease Market, Major Distributors And Channel Partners
  • Table 8: Global Gene Therapy For Parkinson’s Disease Market, Key Technologies & Future Trends
  • Table 9: Global Gene Therapy For Parkinson’s Disease Market, Major Trends
  • Table 10: Global Gene Therapy For Parkinson’s Disease Market, Major End Users
  • Table 11: Global Gene Therapy For Parkinson’s Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Gene Therapy For Parkinson’s Disease Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Gene Therapy For Parkinson’s Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Gene Therapy For Parkinson’s Disease Market - TAM, US$ Billion, 2025
  • Table 15: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Gene Therapy For Parkinson’s Disease Market, Sub-Segmentation Of In Vivo Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Gene Therapy For Parkinson’s Disease Market, Sub-Segmentation Of Ex Vivo Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Gene Therapy For Parkinson’s Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Gene Therapy For Parkinson’s Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Gene Therapy For Parkinson’s Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Gene Therapy For Parkinson’s Disease Market - Company Scoring Matrix
  • Table 98: Merck & Co. Inc. Financial Performance
  • Table 99: Bayer AG Financial Performance
  • Table 100: Sanofi S.A. Financial Performance
  • Table 101: Eli Lilly and Company Financial Performance
  • Table 102: Biogen Inc. Financial Performance
  • Table 103: Global Gene Therapy For Parkinson’s Disease Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Gene Therapy For Parkinson’s Disease Market, Competitive Dashboard
  • Table 105: Global Gene Therapy For Parkinson’s Disease Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Gene Therapy For Parkinson’s Disease Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030
  • Table 107: Global, Gene Therapy For Parkinson’s Disease Market Size Gain ($ Billion), Segmentation By Vector Type, 2025 – 2030
  • Table 108: Global, Gene Therapy For Parkinson’s Disease Market Size Gain ($ Billion), Segmentation By Target Gene, 2025 – 2030

List Of Figures

    Figure 1: Global Gene Therapy For Parkinson’s Disease Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Gene Therapy For Parkinson’s Disease Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Gene Therapy For Parkinson’s Disease Market, Supply Chain Analysis
  • Figure 4: Global Gene Therapy For Parkinson’s Disease Market, Major Raw Material Providers
  • Figure 5: Global Gene Therapy For Parkinson’s Disease Market, Major Resource Providers
  • Figure 6: Global Gene Therapy For Parkinson’s Disease Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Gene Therapy For Parkinson’s Disease Market, Major Distributors And Channel Partners
  • Figure 8: Global Gene Therapy For Parkinson’s Disease Market, Key Technologies & Future Trends
  • Figure 9: Global Gene Therapy For Parkinson’s Disease Market, Major Trends
  • Figure 10: Global Gene Therapy For Parkinson’s Disease Market, Major End Users
  • Figure 11: Global Gene Therapy For Parkinson’s Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Gene Therapy For Parkinson’s Disease Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Gene Therapy For Parkinson’s Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Gene Therapy For Parkinson’s Disease Market - TAM, US$ Billion, 2025
  • Figure 15: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By Delivery Method, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Gene Therapy For Parkinson’s Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Gene Therapy For Parkinson’s Disease Market, Sub-Segmentation Of In Vivo Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Gene Therapy For Parkinson’s Disease Market, Sub-Segmentation Of Ex Vivo Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Gene Therapy For Parkinson’s Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Gene Therapy For Parkinson’s Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Gene Therapy For Parkinson’s Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Gene Therapy For Parkinson’s Disease Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Gene Therapy For Parkinson’s Disease Market, Segmentation By Target Gene, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Gene Therapy For Parkinson’s Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Gene Therapy For Parkinson’s Disease Market - Company Scoring Matrix
  • Figure 98: Merck & Co. Inc. Financial Performance
  • Figure 99: Bayer AG Financial Performance
  • Figure 100: Sanofi S.A. Financial Performance
  • Figure 101: Eli Lilly and Company Financial Performance
  • Figure 102: Biogen Inc. Financial Performance
  • Figure 103: Global Gene Therapy For Parkinson’s Disease Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Gene Therapy For Parkinson’s Disease Market, Competitive Dashboard
  • Figure 105: Global Gene Therapy For Parkinson’s Disease Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Gene Therapy For Parkinson’s Disease Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030
  • Figure 107: Global, Gene Therapy For Parkinson’s Disease Market Size Gain ($ Billion), Segmentation By Vector Type, 2025 – 2030
  • Figure 108: Global, Gene Therapy For Parkinson’s Disease Market Size Gain ($ Billion), Segmentation By Target Gene, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Read More About Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Read More About Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

Read More About Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Read More About Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Cell And Gene Therapy Manufacturing Services Market 2024 – By Type (Gene Therapy, Cell Therapy), By Indication (Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orth...

Neurological Disorder Drugs Market Report 2026 - Global Outlook – By Drug Class (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor Antagonists, Antiepileptic, Antipsychotic And Antidepressant, Other Drugs C...

Gene Therapy Market Report 2026 - Global Outlook – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis,...

Anti-Parkinson Drugs Market Report 2026 - Global Outlook – By Drugs Class (Levodopa Or Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, A...

Nucleic Acid Based Gene Therapy Market Report 2026 - Global Outlook – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologie...

Cell And Gene Therapy Clinical Trial Services Market Report 2026 - Global Outlook – By Service (Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Bio...

Gene Editing Market Report 2026 - Global Outlook – By Technology (CRISPR, TALEN, ZFN ), By Application (Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering), By End Users (Biotechnology, Pharmace...

Cell And Gene Therapy Supply Chain/Logistics Market Report 2026 - Global Outlook – By Type Of Software Solution (Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Infor...

Frequently Asked Questions

The Gene Therapy For Parkinson’s Disease Market Report 2026 market was valued at $0.64 billion in 2025, increased to $0.81 billion in 2026, and is projected to reach $2.05 billion by 2030. request a sample here

The expected CAGR for the Gene Therapy For Parkinson’s Disease Market Report 2026 market during the forecast period 2025–2030 is 26.0%. request a sample here

Major growth driver of the market includes: Growing Interest In Personalized Medicine Driving The Growth Of The Market Due To Rising Demand For Targeted And Effective Treatments in the Gene Therapy For Parkinson’s Disease Market Report 2026 market. For further insights on this market, request a sample here

The gene therapy for parkinson’s disease market covered in this report is segmented –
1) By Therapy Type: In Vivo Gene Therapy, Ex Vivo Gene Therapy
2) By Vector Type: Viral Vectors, Non-Viral Vectors
3) By Target Gene: Aromatic L-Amino Acid Decarboxylase (AADC), Glial Cell Line-Derived Neurotrophic Factor (GDNF), Neurturin, Other Target Genes
4) By Delivery Method: Intracerebral, Intravenous, Other Delivery Methods
5) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users Subsegments:
1) By In Vivo Gene Therapy: Viral Vectors, Non-Viral Vectors
2) By Ex Vivo Gene Therapy: Autologous Cell-Based Gene Therapy, Allogeneic Cell-Based Gene Therapy request a sample here

Major trend in this market includes: Accelerating Development Of Innovative Gene Therapies For further insights on this market, request a sample here.

Major companies operating in the Gene Therapy For Parkinson’s Disease Market Report 2026 market are Major companies operating in the gene therapy for parkinson’s disease market are Merck & Co. Inc., Bayer AG, Sanofi S.A., Eli Lilly and Company, Biogen request a sample here.

North America was the largest region in the gene therapy for parkinson’s disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy for parkinson’s disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us